Simply put, cervical cancer is avoidable. The latest issue of Healthcare Purchasing News highlights how the BD Onclarity™ HPV Assay is shaping the future of women’s health and improving standards of care as the only FDA-approved HPV test that individually identifies high-risk HPV 31.
Discover our latest articles, webinars, press releases and updates in women's health.
Learn more about our BD Women’s Health solutions
This form is only intended for use by healthcare professionals seeking additional information about BD products and solutions. Patients seeking health and treatment information should contact their healthcare professional and can find additional resources from ACOG and the American Cancer Society.
Do not submit protected health information (PHI) or patient information (PII) through this form. If you do submit PHI or PII, your question may not be answered, as the information will be deleted to protect your privacy.
Register Now
Stay informed with the latest updates from BD Women’s Health.